Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paula, Muilu"'
Publikováno v:
In Revue du rhumatisme October 2022 89(5):481-488
Autor:
Paula Muilu, Vappu Rantalaiho, Hannu Kautiainen, Lauri J. Virta, Johan G. Eriksson, Kari Puolakka
Publikováno v:
BMC Rheumatology, Vol 4, Iss 1, Pp 1-8 (2020)
Abstract Background In this retrospective cohort study, we evaluated the drug therapies used for early rheumatoid (RA) and undifferentiated (UA) arthritis patients. Methods From a nationwide register maintained by the Social Insurance Institution, in
Externí odkaz:
https://doaj.org/article/df13b76362c14aa9ac90dbbd3203f3b8
Autor:
Lauri J. Virta, Hannu Kautiainen, Vappu Rantalaiho, Kari Puolakka, Johan G. Eriksson, Paula Muilu
Publikováno v:
Clinical Rheumatology. 38:555-562
To explore the trends in the incidence of idiopathic inflammatory rheumatic diseases (IIRDs) after the turn of the millennium. From a nationwide register maintained by the Social Insurance Institution of Finland, we collected all adult patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef8657256abb813bc22b227783e51aef
https://doi.org/10.1007/s10067-018-4310-0
https://doi.org/10.1007/s10067-018-4310-0
Publikováno v:
The Journal of rheumatology. 47(8)
Objective.To assess to what extent the worldwide opioid epidemic affects Finnish patients with early inflammatory arthritis (IA).Methods.From the nationwide register maintained by the Social Insurance Institution of Finland, we collected all incident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db80e0d28180cb1b7eb402a5ce9e6b2d
https://pubmed.ncbi.nlm.nih.gov/31615910
https://pubmed.ncbi.nlm.nih.gov/31615910
Publikováno v:
Spondyloarthritis – treatment.
Background Disease-modifying anti-rheumatic drugs (DMARDs) are introduced for the treatment of spondyloarthritis (SpA) after failure of non-steroidal anti-inflammatory drugs (NSAIDs). In Finland, try out with a conventional synthetic DMARD (csDMARD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d23400d672ba1576822ddaaab2556c4
https://doi.org/10.1136/annrheumdis-2019-eular.1138
https://doi.org/10.1136/annrheumdis-2019-eular.1138
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Treatment outcomes in inflammatory arthritis (IA) have improved during the past decades; however, pain management remains a great challenge. There has been a concern of overprescription of opioids during recent years. Objectives The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02349f3fec7d16be414bf97bfdcf15f4
https://doi.org/10.1136/annrheumdis-2018-eular.4270
https://doi.org/10.1136/annrheumdis-2018-eular.4270
Publikováno v:
Poster Presentations.
Background Inflammatory joint disorders (IJD) are associated with cardiovascular (CV) problems, including coronary heart disease (CHD). This association is best known for rheumatoid arthritis (RA); but also for ankylosing spondylitis and psoriatic ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b2027bfa39086f2e928b103dac2579a
https://doi.org/10.1136/annrheumdis-2017-eular.2027
https://doi.org/10.1136/annrheumdis-2017-eular.2027